Source: International Congress 2018 – Treatments that can serve as an alternative to positive airway pressure (PAP)
Disease area: Sleep and breathing disorders



Rating:

Share or cite this content

Citations should be made in the following way:
D. Krasimirova (Sofia, Bulgaria), D. Petrova (Sofia, Bulgaria), O. Georgiev (Sofia, Bulgaria), R. Bilyukov (Sofia, Bulgaria), T. Mondeshki (Sofia, Bulgaria), M. Nikolov (Sofia, Bulgaria), A. Tzakova (Sofia, Bulgaria), V. Pencheva Genova (Sofia, Bulgaria), B. Stancheva (Sofia, Bulgaria), S. Naydenska (Sofia, Bulgaria), P. Shoshkov (Sofia, Bulgaria). One year vitamin D and parathyroid hormone influence in patients with OSAS and CPAP treatment. 4338

Member's Comments

No comment yet.

Related content which might interest you: Vitamin D (25OHD3) and parathyroid hormone (PTH) status in patients with COPD Source: Annual Congress 2007 - Managing COPD in primary care Year: 2007 1,25-dihydroxyvitamin D3 effect on corticosteroid sensitivity in obese asthmatic patients before and after bariatric surgery Source: Virtual Congress 2020 – New insight into the immunology of asthma and COPD Year: 2020 Efficacy and safety of calcium and vitamin D3 in treatment of steroid osteoporosis in asthmatic patients Source: Eur Respir J 2001; 18: Suppl. 33, 53s Year: 2001 Parathyroid hormone: a neglected biomarker of exacerbations and hospitalizations in patients with COPD and hypovitaminosis D. Source: Virtual Congress 2021 – Prediction of exacerbations in patients with COPD Year: 2021 Vitamin D and parathyroid hormone in critically ill septic patients: a prospective study Source: Virtual Congress 2021 – Mechanical ventilation and weaning Year: 2021 Growth hormone (GH) response to GH-releasing hormone (GHRH) in asthmatic patients during long-term inhaled corticosteroids (ICS) treatment Source: Eur Respir J 2003; 22: Suppl. 45, 419s Year: 2003 Using hormone replacement therapy in perimenopausal women with bronchial asthma (BA) Source: Annual Congress 2007 - Novel issues in the treatment and control of asthma Year: 2007 Serum vitamin D levels in patients with obstructive sleep apnea syndrome and concentration changes after continuous positive airway pressure treatment Source: Virtual Congress 2020 – Treatment of obstructive sleep apnoea and its effects Year: 2020 Effect of systemic steroid treatment on serum leptin levels in patients with COPD exacerbation Source: Eur Respir J 2005; 26: Suppl. 49, 284s Year: 2005 Serum vitamin C level in patients with acute pneumonia and in COPD patients before and after therapy Source: Eur Respir J 2006; 28: Suppl. 50, 38s Year: 2006 The influence of glucocorticoid therapy on the level of sex hormones in menopausal women with bronchial asthma Source: Eur Respir J 2002; 20: Suppl. 38, 51s Year: 2002 Plasma leptin in asthma patients with steroid induced diabetes compared with obesity patients Source: Eur Respir J 2007; 30: Suppl. 51, 555s Year: 2007 Relationship between structural bone changes assessed by ultrasound bone densitometry (UBD) and growth hormone (GH) during chronic treatment with inhaled corticosteroids (ICS) in asthmatic patients Source: Eur Respir J 2003; 22: Suppl. 45, 419s Year: 2003 Serum sex hormone levels in COPD patients and its relation with hypoxaemia and pulmonary functions Source: Eur Respir J 2001; 18: Suppl. 33, 213s Year: 2001 3 month continuous positive airway pressure (CPAP) therapy decreases serum lipids, but not homocysteine and leptin concentration in patients with OSAS Source: Annual Congress 2009 - Continuous positive airway pressure therapy in obstructive sleep apnoea Year: 2009 Plasma vitamin D concentration and clinical characteristics in clinically stable patients with moderate COPD Source: Annual Congress 2011 - Physiological basis of respiratory disease Year: 2011 Sleep apnoea and quality of life in growth hormone deficient adults before and six months following growth hormone therapy Source: Eur Respir J 2005; 26: Suppl. 49, 570s Year: 2005 Serum vitamin D level is associated with emphysema progression in male patients with COPD Source: International Congress 2017 – Markers of COPD progression Year: 2017 Biomarker-high patients and steroid responsiveness Source: International Congress 2018 – PG17 Asthma phenotyping Year: 2018 The effect of methylxanthine, corticosteroid, and N -acetylcystein on plasma oxidant/antioxidant levels in patients with COPD Source: Eur Respir J 2001; 18: Suppl. 33, 215s Year: 2001